Clinical Trials Directory

Trials / Sponsors / International Vaccine Institute

International Vaccine Institute

Academic / Other · 46 registered clinical trials10 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingSafety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants
Cholera Vaccination Reaction
Phase 12027-01-01
Not Yet RecruitingStrengthening HPV Immunization Through EPI Leveraged Delivery
HPV Vaccine
Phase 22026-01-16
RecruitingAge-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and
Cholera Vaccination
Phase 22026-01-13
RecruitingTrial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvicho
Cholera Vaccination
Phase 32025-10-31
RecruitingEffectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease
Invasive Non-Typhoidal Salmonella Disease, Malaria, Malaria Vaccine
2025-10-27
Not Yet RecruitingEvaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)
Mpox (Monkeypox), Mpox
2025-09-30
Not Yet RecruitingHepatitis B Vaccine Delivered Trans-dermally by MAP
Hepatitis B Vaccine
Phase 12025-02-05
RecruitingSafety and Immunogenicity of Hecolin® in Healthy Pregnant Women
Hepatitis E Infection
Phase 22024-05-02
RecruitingImmunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children
Hepatitis E Virus Infection
Phase 22024-04-04
RecruitingGlobal Burden Estimation of Human Papillomavirus (GLOBE-HPV)
HPV Infection
2023-11-23
CompletedA Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candi
Schistosomiasis
Phase 12023-11-17
CompletedDose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Ad
Cholera Vaccination Reaction
Phase 12022-12-05
UnknownEffectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique
Sars-CoV-2 Infection
2022-02-24
UnknownEffectiveness of a Typhoid Conjugate Vaccine in DRC
Typhoid Fever
Phase 42022-02-11
UnknownMix and Match Heterologous Prime-Boost Study Using Approved COVID-19 Vaccines
Covid19
Phase 22021-12-29
CompletedImmune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanc
Cholera
Phase 32021-10-06
UnknownEfficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronaviru
COVID-19 Disease
Phase 32021-10-01
UnknownEvaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana
Typhoid Fever
Phase 42021-08-24
UnknownTyVECO: Surveillance Protocol
Typhoid Fever, Intestinal Perforation
2021-08-09
TerminatedSeamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asi
Chikungunya
Phase 2 / Phase 32021-08-01
CompletedSafety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVI
Coronavirus Infection, SARS-CoV 2
Phase 1 / Phase 22020-07-15
CompletedImmune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III
Typhoid
Phase 32020-02-04
UnknownImmune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine
Typhoid
Phase 32019-11-15
UnknownEffectiveness of Single Dose or Two Doses of Bivalent HPV Vaccine in Thailand
Healthy
N/A2018-12-17
CompletedSafety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine
Typhoid
Phase 22018-04-18
CompletedSafety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
Typhoid
Phase 12016-05-19
UnknownSafety and Immunogenicity of a New Formulation of Euvichol®
Cholera
Phase 32016-03-01
UnknownSafety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
Cholera, Diarrhea, Vibrio Infections
Phase 22015-12-01
UnknownEffectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine
Cholera
2013-03-01
CompletedBridging Study for Killed Oral Cholera Vaccine in Ethiopia
Vibrio Cholerae, Cholera
Phase 42012-12-01
CompletedExploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Poliomyelitis, Tropical Enteropathy
Phase 12012-03-01
CompletedA Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults
Vibrio Cholerae
Phase 42012-03-01
CompletedImmunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual
Healthy
Phase 12011-12-01
CompletedPilot Introduction of Oral Cholera Vaccine in Orissa, India
Cholera
2011-05-01
CompletedStudy of Alternative Vaccination Schedule of Oral Cholera Vaccine
Cholera, Diarrhoea, Vibrio Infection
Phase 22010-12-01
CompletedSafety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Cholera, Vibrio Infections, Diarrhea
Phase 22010-07-01
CompletedMass Oral Cholera Vaccination in Zanzibar
Cholera, Diarrhea
N/A2009-01-01
TerminatedSafety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi
Cholera, Diarrhea, Vibrio Infections
Phase 22008-11-01
CompletedImmunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine
Cholera, Diarrhea, Vibrio Infections
Phase 22007-06-01
CompletedRandomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
Diarrhea, Cholera, Vibrio Infections
Phase 32006-07-01
CompletedSafety and Immunogenicity of Oral Cholera Vaccine in Kolkata
Cholera
Phase 22005-08-01
CompletedSafety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine
Cholera
Phase 22005-05-01
CompletedEvaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
Typhoid, Paratyphoid Fever
Phase 42003-05-01
CompletedIntroduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Typhoid, Paratyphoid Fever
Phase 42001-12-01
CompletedCombined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Typhoid, Paratyphoid Fever
Phase 42001-10-01
CompletedTyphoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
Typhoid, Paratyphoid Fever
Phase 42001-10-01